Description: Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients. It operates through pharmaceutical industry, pharmaceutical wholesale and distribution, and pharmaceutical retail business segments. The company offers active pharmaceutical ingredients, which include succimer, urea, paeonol, felodipine, doxazosin mesylate, sodium 2,3-dimercapto-1-propanesulfonate, zofenopril calcium and troxerutin; and medical preparations, such as felodipine, doxazosin mesylate, melbinum glipizide, yiqihewei capsule, kunning granule, armillariella oral solution, paeonol ointment, and urea and vitamin E cream, as well as kecuo yintong and compound golden larch bark gel. In addition, it provides medical intermediate including penicillamine, 3-mercapto-1-propanol, sodium paeonolsilate, and sodium 2,3-dimercapto-1-propanesulfonate; and plant extract products, such as clove and evening primrose oil, herba clinopodii P.E, quercetin, and taxifolin. The company was founded in 2002 and is headquartered in Hefei, China.
Home Page: www.lifeonapi.com
No 126, KeXue avenue
Hefei,
230088
China
Phone:
86 551 6535 0389
Officers
| Name | Title |
|---|---|
| Ms. Xiaojuan Deng | Vice Chairman & GM |
| Mr. Shaobing Gou | Financial Director |
| Mr. Jun Chen | R&D Director & Non-Independent Director |
| Mr. Jun Xia | Deputy GM & Sec. of the Board |
| Ms. Qing Wang | Deputy Gen. Mang. and Non-Independent Director |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 19.7967 |
| Price-to-Book MRQ: | 3.0438 |
| Price-to-Sales TTM: | 1.7529 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1141 |